Titre du document / Document title
Bioequivalence study of generic acyclovir compared with the brand name Acyclovir®
Auteur(s) / Author(s)
ROJANASTHIEN Noppamas
(1) ;
KUMSORN Boonyium
(1) ;
YUEN KAH HAY
(2) ;
TEEKACHUNHATEAN Supanimit
(1) ;
CHAICHANA Nuchanart
(1) ;
Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)
(1) Division of Clinical Pharmacology, Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, THAILANDE
(2) School of Pharmaceutical Sciences, University of Science Malaysia, 11800 Minden, Penang, MALAISIE
Résumé / Abstract
The bioequivalence study of 200-mg generic acyclovir was conducted in healthy males. The reference Zovirax® and the test Zevin® were administered as a single oral dose after an overnight fast in a two-period, crossover design separated by 1 week. Serial blood samples were collected over a period of 24 hours. Plasma acyclovir concentrations were determined by HPLC and the pharmacokinetic parameters were analyzed by non-compartmental analysis. Results: The t
1/2 for the test (4.5 ± 2.4 h) and Zovirax® (3.9 ± 2.6 h) were comparable. The analysis of variance was carried out and the median T
max (1.50 h) for the test was not statistically difference from Zovirax®. The mean (90% CI) of the AUC
0-∞ and the C
max ratios for (Test/Reference) were 0.95 (0.83 - 1.09) and 0.95 (0.83 - 1.10), respectively. These values fell within the bioequivalence criteria of 0.80 - 1.25, thus it was concluded that Zevin® and Zovirax® were bioequivalence.
Revue / Journal Title
Chot Mai Het Thang Phaet
ISSN 0125-2208
CODEN JMTHBU
Source / Source
2002, vol. 85, n
o10, pp. 1121-1129 [9 page(s) (article)] (14 ref.)
Langue / Language
Anglais
Editeur / Publisher
Medical Association of Thailand, Bangkok, THAILANDE
(1919)
(Revue)
Mots-clés anglais / English Keywords
Purine nucleoside ;
Acyclic nucleoside ;
Bioavailability ;
Concentration ;
High performance ;
Liquid chromatography ;
Generic drug ;
Bioequivalence ;
Pharmacokinetics ;
Pharmacology ;
Experimental study ;
Volunteer ;
Human ;
Antiviral ;
Aciclovir ;
Mots-clés français / French Keywords
Purine nucléoside ;
Nucléoside acyclique ;
Biodisponibilité ;
Concentration ;
Haute performance ;
Chromatographie phase liquide ;
Médicament générique ;
Bioéquivalence ;
Pharmacocinétique ;
Pharmacologie ;
Etude expérimentale ;
Volontaire ;
Homme ;
Antiviral ;
Aciclovir ;
Mots-clés espagnols / Spanish Keywords
Purina nucleósido ;
Nucleósido acíclico ;
Biodisponibilidad ;
Concentración ;
Alto rendimiento ;
Cromatografía fase líquida ;
Medicamento genérico ;
Bioequivalencia ;
Farmacocinética ;
Farmacología ;
Estudio experimental ;
Voluntario ;
Hombre ;
Antiviral ;
Aciclovir ;
Localisation / Location
INIST-CNRS, Cote INIST : 17480, 35400010572163.0120
Nº notice refdoc (ud4) : 14453990